News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Nivolumab with and without ipilimumab in solid tumors of high mutational burden – Journal for ImmunoTherapy of Cancer
Photo from pediatriconcall.com
Aug 9, 2024, 05:53

Nivolumab with and without ipilimumab in solid tumors of high mutational burden – Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer shared a post on X, about recent paper published in Journal for ImmunoTherapy of Cancer:

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.

Authors: Michael Schenker, Mauricio Burotto, Martin Richardet, Tudor-Eliade Ciuleanu, Anthony Gonçalves, Neeltje Steeghs, Patrick Schoffski, Paolo A. Ascierto, Michele Maio, Iwona Lugowska, Lorena Lupinacci, Alexandra Leary, Jean-Pierre Delord, Julieta Grasselli, David S. P. Tan, Jennifer Friedmann, Jacqueline Vuky, Marina Tschaika, Somasekhar Konduru, Sai Vikram Vemula, Ruta Slepetis, Georgia Kollia, Misena Pacius, Quyen Duong, Ning Huang, Parul Doshi, Jonathan Baden, Massimo Di Nicola.

Journal for ImmunoTherapy of Cancer

”New JITC article: Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.”

Journal for ImmunoTherapy of Cancer

Source: Journal for ImmunoTherapy of Cancer/X

Alexandra Leary Anthony Gonçalves cancer David S. P. Tan Georgia Kollia Iwona Lugowska Jacqueline Vuky Jean-Pierre Delord Jennifer Friedmann JITC Jonathan Baden Journal for ImmunoTherapy of Cancer Julieta Grasselli Lorena Lupinacci Marina Tschaika Martin Richardet Massimo Di Nicola Mauricio Burotto Michael Schenker Michele Maio Misena Pacius Neeltje Steeghs Ning Huang nivolumab OncoDaily Oncology Paolo A. Ascierto Parul Doshi Patrick Schöffski pilimumab Quyen Duong Ruta Slepetis Sai Vikram Vemula solid tumors Somasekhar Konduru Tudor-Eliade Ciuleanu
Special Coverage
Blog
Nov 13, 2024, 11:56
HER2-Low Status and Its Impact on Outcomes in Early-Stage Triple-Negative Breast Cancer
Blog
Nov 13, 2024, 11:52
Andrew Pannu: Analysis of Big Pharma Therapeutic M&A Deals from 2019 to today
Blog
Nov 13, 2024, 11:48
Indoor cooking with solid fuels can increase lung cancer risk - IASLC
Blog
Nov 13, 2024, 11:44
Registration for the AACR Annual Meeting 2025 is now open
Blog
Nov 13, 2024, 11:39
i4KIDS I i4KIDS-EUROPE - Ship2B Ventures Impact Forum
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women